Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene

International Journal of Cancer. Journal International Du Cancer
Laurent ChêneAlain Latil

Abstract

Loss of heterozygosity (LOH) on chromosome arm 7q31 is found in many prostate tumors. Such alterations are generally associated with inactivation of tumor suppressor genes. It has been shown previously that the main region of LOH at 7q31 spans the interval between the D7S486 and D7S2460 microsatellite loci, which contains several candidate tumor suppressor genes (TSG) such as TES, CAV2, CAV1, MET, CAPZA2, ST7 and WNT2. We tested 41 human sporadic prostate tumors for 7q31 LOH by using 5 polymorphic markers overlapping the critical region and used a real-time reverse transcriptase-polymerase chain reaction (RT-PCR) assay to study the expression of the 7 candidate TSGs located in this genomic region. We found that CAV1, CAV2, MET and TES mRNA expression was lower in prostate tumors than in normal prostate tissues. Our immunohistochemical results and previously published data on the compartmental expression of these messenger RNAs in stromal and epithelial cells suggest that TES is the best candidate tumor suppressor gene at 7q31.

References

Jan 1, 1992·The Prostate. Supplement·F H SchröderM Pavone-Macaluso
Feb 1, 1967·The Journal of Urology·G T MellingerJ Bailar
Jul 1, 1994·Genes, Chromosomes & Cancer·D MacGroganR Bookstein
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·P E SchererM P Lisanti
Nov 1, 1995·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·A LatilR Lidereau
Jul 6, 2000·Laboratory Investigation; a Journal of Technical Methods and Pathology·J C AlersH van Dekken
Dec 1, 2001·Nature Genetics·K A HughesD M Black
Feb 7, 2003·Journal of Cell Science·Amanda S CouttsDonald M Black
Feb 13, 2003·Drugs of Today·Jian-Hua Luo
Nov 25, 2003·Apoptosis : an International Journal on Programmed Cell Death·T C ThompsonA Goltsov

❮ Previous
Next ❯

Citations

Jul 25, 2013·International Journal of Molecular Sciences·Aaron RobertsonAlison Curnow
Jun 15, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Zhenpeng GuJinxiu Cui
Aug 15, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yang YongbinJiao Manjing
Feb 13, 2009·Cancer Investigation·Donkena Krishna VanajaCharles Y F Young
Jun 3, 2011·Translational Oncology·François D'AnjouRobert Day
Jul 12, 2008·Cancer Genetics and Cytogenetics·Antoine ItalianoFlorence Pedeutour
Feb 14, 2007·The Journal of Urology·Xin LiuJohn S Witte
Sep 11, 2012·Cancer Science·Jiang ZhuQifeng Yang
Feb 28, 2015·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Ruofan DongCaiping Mao
Apr 20, 2006·Journal of Cellular Biochemistry·M P ImrehL Ahrlund-Richter
Jun 11, 2005·The Prostate·Juergen HaeuslerChristiane Maier
Oct 26, 2018·Pathology Oncology Research : POR·Aneta PopielPiotr Dzięgiel
Jul 4, 2013·Molecular Medicine Reports·Miao HeZi-Wei Wang
Dec 22, 2016·Oncology Reports·Ming WangLi-Nian Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caveolins & Signal Transduction

Caveolins are small proteins with a hairpin loop conformation that are located in the plasma membrane of various cell types where they bind cholesterol and interact with receptors essential for several signal transduction pathways. Here is the latest research.